Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
As of today, Eli Lilly(LLY) shares are valued at $1,225.18. The company's market cap stands at 1.15T, with a P/E ratio of 44.48 and a dividend yield of 0.52%.
During the trading session on 2026-07-08, Eli Lilly(LLY) shares reached a daily high of $1,241.89 and a low of $1,204.16. At a current price of $1,225.18, the stock is +1.7% higher than the low and still -1.3% under the high.
Trading volume for Eli Lilly(LLY) stock has reached 1.21M, versus its average volume of 3.54M.
The stock's 52-week range extends from a low of $623.78 to a high of $1,249.45.
The stock's 52-week range extends from a low of $623.78 to a high of $1,249.45.
LLY News
Eli Lilly’s (LLY) stock is getting a boost on an otherwise down day for markets on news that its drug to treat the skin condition eczema has been approved in Ca...
...
Key Points Eli Lilly's new oral obesity drug, Foundayo, removes many of the barriers that have limited GLP-1 adoption, potentially expanding the addressable ma...
Analyst ratings
84%
of 31 ratingsMore LLY News
RBC Capital raised the firm’s price target on Eli Lilly (LLY) to $1,500 from $1,250 and keeps an Outperform rating on the shares in a preview of its Q2 results....
Eli Lilly stock has surged over the past few years, and at around US$1,235 per share today, investors face a clear tension between strong price momentum and mix...
Key Points Becton, Dickinson supplies equipment whose demand is soaring due to the rise of GLP-1 medicines. Abbott Laboratories' most important growth driver...
Key Points Eli Lilly and Intuitive Surgical are top players in their respective corners of the healthcare market. Both companies are highly innovative and boa...
Yves Herman / Reuters The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET....
Key Points Eli Lilly's growth rate has been accelerating over the past year due to its GLP-1 drugs. The recent approval of its GLP-1 pill, Foundayo, could off...
Key Points The obesity drug industry is likely a decade-long tailwind for Eli Lilly's business. Foundayo and Retatrutide could cement a decade of growth. The...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.